OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex proteins. Enhancing these processes involves fine-tuning various factors, including cell line engineering, media formulation, and bioreactor conditions. A key goal is to maximize antibody yield while reducing production costs